Associations of insulin resistance and type 2 diabetes to heart failure: Epidemiology, potential mechanisms, and clinical perspectives

被引：0

作者：

Ingelsson E. ^{[1
]}

机构：

[1] Department of Public Health and Caring Sciences, Uppsala University, SE-751 85 Uppsala, Uppsala Science Park

来源：

Current Cardiovascular Risk Reports | 2008年 / 2卷 / 1期

关键词：

Heart Failure; Insulin Resistance; Metformin; Chronic Heart Failure; Heart Failure Patient;

D O I：

10.1007/s12170-008-0012-5

中图分类号：

学科分类号：

摘要：

Heart failure, a common condition in most industrialized nations, is disabling and deadly. Type 2 diabetes, recognized as a risk factor for incident heart failure more than three decades ago, consistently has been associated with a twofold to threefold increased risk of heart failure and type 2 diabetes often coexist, and several studies have shown that type 2 diabetes in heart failure patients is associated with markedly increased mortality. Insulin resistance recently was reported to be a predictor of heart failure incidence independent of established risk factors, including diabetes and obesity. This review summarizes the literature regarding the associations of insulin resistance and type 2 diabetes to heart failure, and it discusses potential mechanisms underlying these associations and clinical perspectives. © 2008 Current Medicine Group LLC.

引用

页码：60 / 65

页数：5

共 50 条

[11]

Roger V.L., Weston S.A., Redfield M.M., Et al., Trends in heart failure incidence and survival in a community-based population, Jama, 292, pp. 344-350, (2004)

[12]

From A.M., Leibson C.L., Bursi F., Et al., Diabetes in heart failure: prevalence and impact on outcome in the population, Am J Med, 119, pp. 591-599, (2006)

[13]

Pocock S.J., Wang D., Pfeffer M.A., Et al., Predictors of mortality and morbidity in patients with chronic heart failure, Eur Heart J, 27, pp. 65-75, (2006)

[14]

Smooke S., Horwich T.B., Fonarow G.C., Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure, Am Heart J, 149, pp. 168-174, (2005)

[15]

Newton J.D., Squire I.B., Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure, Heart, 92, pp. 1441-1446, (2006)

[16]

Swan J.W., Walton C., Godsland I.F., Et al., Insulin resistance in chronic heart failure, Eur Heart J, 15, pp. 1528-1532, (1994)

[17]

Swan J.W., Anker S.D., Walton C., Et al., Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure, J Am Coll Cardiol, 30, pp. 527-532, (1997)

[18]

Paolisso G., Tagliamonte M.R., Rizzo M.R., Et al., Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease, Am J Cardiol, 83, pp. 1338-1344, (1999)

[19]

Suskin N., McKelvie R.S., Burns R.J., Et al., Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure, Eur Heart J, 21, pp. 1368-1375, (2000)

[20]

Doehner W., Rauchhaus M., Ponikowski P., Et al., Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure, J Am Coll Cardiol, 46, pp. 1019-1026, (2005)

← 1 2 3 4 5 →